Skip to main content
Top
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Study protocol

Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies

Authors: Prue Cormie, Suzanne K Chambers, Robert U Newton, Robert A Gardiner, Nigel Spry, Dennis R Taaffe, David Joseph, M Akhlil Hamid, Peter Chong, David Hughes, Kyra Hamilton, Daniel A Galvão

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

Despite being a critical survivorship care issue, there is a clear gap in current knowledge of the optimal treatment of sexual dysfunction in men with prostate cancer. There is sound theoretical rationale and emerging evidence that exercise may be an innovative therapy to counteract sexual dysfunction in men with prostate cancer. Furthermore, despite the multidimensional aetiology of sexual dysfunction, there is a paucity of research investigating the efficacy of integrated treatment models. Therefore, the purpose of this study is to: 1) examine the efficacy of exercise as a therapy to aid in the management of sexual dysfunction in men with prostate cancer; 2) determine if combining exercise and brief psychosexual intervention results in more pronounced improvements in sexual health; and 3) assess if any benefit of exercise and psychosexual intervention on sexual dysfunction is sustained long term.

Methods/Design

A three-arm, multi-site randomised controlled trial involving 240 prostate cancer survivors will be implemented. Participants will be randomised to: 1) ‘Exercise’ intervention; 2) ‘Exercise + Psychosexual’ intervention; or 3) ‘Usual Care’. The Exercise group will receive a 6-month, group based, supervised resistance and aerobic exercise intervention. The Exercise + Psychosexual group will receive the same exercise intervention plus a brief psychosexual self-management intervention that addresses psychological and sexual well-being. The Usual Care group will maintain standard care for 6 months. Measurements for primary and secondary endpoints will take place at baseline, 6 months (post-intervention) and 1 year follow-up. The primary endpoint is sexual health and secondary endpoints include key factors associated with sexual health in men with prostate cancer.

Discussion

Sexual dysfunction is one of the most prevalent and distressing consequences of prostate cancer. Despite this, very little is known about the management of sexual dysfunction and current health care services do not adequately meet sexual health needs of survivors. This project will examine the potential role of exercise in the management of sexual dysfunction and evaluate a potential best-practice management approach by integrating pharmacological, physiological and psychological treatment modalities to address the complex and multifaceted aetiology of sexual dysfunction following cancer.

Trial registration

Australian New Zealand Clinical Trials Registry ACTRN12613001179​729.
Appendix
Available only for authorised users
Literature
1.
go back to reference Australian Institute of Health and Welfare & Australasian Association of Cancer Registries 2012: Cancer in Australia: an overview. Cancer series no. 74. Cat. no. CAN 70. 2012, Canberra: AIHW Australian Institute of Health and Welfare & Australasian Association of Cancer Registries 2012: Cancer in Australia: an overview. Cancer series no. 74. Cat. no. CAN 70. 2012, Canberra: AIHW
2.
go back to reference Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Arul M, Eric K, Adam K, Pisters LL, Deborah K, Irving K, David W, Jay C, Nikhil S, Wei JT: Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008, 358 (12): 1250-1261. 10.1056/NEJMoa074311.CrossRefPubMed Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Arul M, Eric K, Adam K, Pisters LL, Deborah K, Irving K, David W, Jay C, Nikhil S, Wei JT: Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008, 358 (12): 1250-1261. 10.1056/NEJMoa074311.CrossRefPubMed
3.
go back to reference Bober SL, Varela VS: Sexuality in adult cancer survivors: challenges and intervention. J Clin Oncol. 2012, 30 (30): 3712-3719. 10.1200/JCO.2012.41.7915.CrossRefPubMed Bober SL, Varela VS: Sexuality in adult cancer survivors: challenges and intervention. J Clin Oncol. 2012, 30 (30): 3712-3719. 10.1200/JCO.2012.41.7915.CrossRefPubMed
4.
go back to reference Sadovsky R, Basson R, Krychman M, Morales AM, Schover L, Wang R, Incrocci L: Cancer and sexual problems. J Sex Med. 2010, 7 (1 Pt 2): 349-373.CrossRefPubMed Sadovsky R, Basson R, Krychman M, Morales AM, Schover L, Wang R, Incrocci L: Cancer and sexual problems. J Sex Med. 2010, 7 (1 Pt 2): 349-373.CrossRefPubMed
5.
go back to reference Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Potosky AL, Stanford JL, Stroup AM, Lawrence Van Horn R, Penson DF: Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med. 2013, 368 (5): 436-445. 10.1056/NEJMoa1209978.CrossRefPubMedPubMedCentral Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Potosky AL, Stanford JL, Stroup AM, Lawrence Van Horn R, Penson DF: Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med. 2013, 368 (5): 436-445. 10.1056/NEJMoa1209978.CrossRefPubMedPubMedCentral
6.
go back to reference Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, Albertsen PC, Harlan LC, Potosky AL: Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA. 2000, 283 (3): 354-360. 10.1001/jama.283.3.354.CrossRefPubMed Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, Albertsen PC, Harlan LC, Potosky AL: Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA. 2000, 283 (3): 354-360. 10.1001/jama.283.3.354.CrossRefPubMed
7.
go back to reference Spry NA, Kristjanson L, Hooton B, Hayden L, Neerhut G, Gurney H, Corica T, Korbel E, Weinstein S, McCaul K: Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer. Eur J Cancer. 2006, 42 (8): 1083-1092. 10.1016/j.ejca.2006.01.029.CrossRefPubMed Spry NA, Kristjanson L, Hooton B, Hayden L, Neerhut G, Gurney H, Corica T, Korbel E, Weinstein S, McCaul K: Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer. Eur J Cancer. 2006, 42 (8): 1083-1092. 10.1016/j.ejca.2006.01.029.CrossRefPubMed
8.
go back to reference Hamilton AS, Stanford JL, Gilliland FD, Albertsen PC, Stephenson RA, Hoffman RM, Eley JW, Harlan LC, Potosky AL: Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. J Clin Oncol. 2001, 19 (9): 2517-2526.PubMed Hamilton AS, Stanford JL, Gilliland FD, Albertsen PC, Stephenson RA, Hoffman RM, Eley JW, Harlan LC, Potosky AL: Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. J Clin Oncol. 2001, 19 (9): 2517-2526.PubMed
9.
go back to reference Parker WR, Wang R, He C, Wood DP: Five year expanded prostate cancer index composite-based quality of life outcomes after prostatectomy for localized prostate cancer. BJU Int. 2011, 107 (4): 585-590. 10.1111/j.1464-410X.2010.09579.x.CrossRefPubMed Parker WR, Wang R, He C, Wood DP: Five year expanded prostate cancer index composite-based quality of life outcomes after prostatectomy for localized prostate cancer. BJU Int. 2011, 107 (4): 585-590. 10.1111/j.1464-410X.2010.09579.x.CrossRefPubMed
10.
go back to reference Higano CS: Sexuality and intimacy after definitive treatment and subsequent androgen deprivation therapy for prostate cancer. J Clin Oncol. 2012, 30 (30): 3720-3725. 10.1200/JCO.2012.41.8509.CrossRefPubMed Higano CS: Sexuality and intimacy after definitive treatment and subsequent androgen deprivation therapy for prostate cancer. J Clin Oncol. 2012, 30 (30): 3720-3725. 10.1200/JCO.2012.41.8509.CrossRefPubMed
11.
go back to reference Ng E, Woo HH, Turner S, Leong E, Jackson M, Spry N: The influence of testosterone suppression and recovery on sexual function in men with prostate cancer: observations from a prospective study in men undergoing intermittent androgen suppression. J Urol. 2012, 187 (6): 2162-2167. 10.1016/j.juro.2012.01.080.CrossRefPubMed Ng E, Woo HH, Turner S, Leong E, Jackson M, Spry N: The influence of testosterone suppression and recovery on sexual function in men with prostate cancer: observations from a prospective study in men undergoing intermittent androgen suppression. J Urol. 2012, 187 (6): 2162-2167. 10.1016/j.juro.2012.01.080.CrossRefPubMed
12.
go back to reference Elliott S, Latini DM, Walker LM, Wassersug R, Robinson JW: Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life. J Sex Med. 2010, 7 (9): 2996-3010. 10.1111/j.1743-6109.2010.01902.x.CrossRefPubMed Elliott S, Latini DM, Walker LM, Wassersug R, Robinson JW: Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life. J Sex Med. 2010, 7 (9): 2996-3010. 10.1111/j.1743-6109.2010.01902.x.CrossRefPubMed
13.
go back to reference Reese JB: Coping with sexual concerns after cancer. Curr Opin Oncol. 2011, 23 (4): 313-321. 10.1097/CCO.0b013e3283446416.CrossRefPubMed Reese JB: Coping with sexual concerns after cancer. Curr Opin Oncol. 2011, 23 (4): 313-321. 10.1097/CCO.0b013e3283446416.CrossRefPubMed
14.
go back to reference Penson DF, Latini DM, Lubeck DP, Wallace K, Henning JM, Lue TOM: Is quality if life different for Men with erectile dysfunction and prostate cancer compared to Men with erectile dysfunction due to other causes? results from the ExCEED data base. J Urol. 2003, 169 (4): 1458-1461. 10.1097/01.ju.0000054462.88306.43.CrossRefPubMed Penson DF, Latini DM, Lubeck DP, Wallace K, Henning JM, Lue TOM: Is quality if life different for Men with erectile dysfunction and prostate cancer compared to Men with erectile dysfunction due to other causes? results from the ExCEED data base. J Urol. 2003, 169 (4): 1458-1461. 10.1097/01.ju.0000054462.88306.43.CrossRefPubMed
15.
go back to reference Singer PA, Tasch ES, Stocking C, Rubin S, Siegler M, Weichselbaum R: Sex or survival: trade-offs between quality and quantity of life. J Clin Oncol. 1991, 9 (2): 328-334.PubMed Singer PA, Tasch ES, Stocking C, Rubin S, Siegler M, Weichselbaum R: Sex or survival: trade-offs between quality and quantity of life. J Clin Oncol. 1991, 9 (2): 328-334.PubMed
16.
go back to reference Smith DP, Supramaniam R, King MT, Ward J, Berry M, Armstrong BK: Age, health, and education determine supportive care needs of men younger than 70 years with prostate cancer. J Clin Oncol. 2007, 25 (18): 2560-2566. 10.1200/JCO.2006.09.8046.CrossRefPubMed Smith DP, Supramaniam R, King MT, Ward J, Berry M, Armstrong BK: Age, health, and education determine supportive care needs of men younger than 70 years with prostate cancer. J Clin Oncol. 2007, 25 (18): 2560-2566. 10.1200/JCO.2006.09.8046.CrossRefPubMed
17.
go back to reference Miles CL, Candy B, Jones L, Williams R, Tookman A, King M: Interventions for sexual dysfunction following treatments for cancer. Cochrane Database Syst Rev. 2007, 4: CD005540 Miles CL, Candy B, Jones L, Williams R, Tookman A, King M: Interventions for sexual dysfunction following treatments for cancer. Cochrane Database Syst Rev. 2007, 4: CD005540
18.
go back to reference Magheli A, Burnett AL: Erectile dysfunction following prostatectomy: prevention and treatment. Nat Rev Urol. 2009, 6 (8): 415-427. 10.1038/nrurol.2009.126.CrossRefPubMed Magheli A, Burnett AL: Erectile dysfunction following prostatectomy: prevention and treatment. Nat Rev Urol. 2009, 6 (8): 415-427. 10.1038/nrurol.2009.126.CrossRefPubMed
19.
go back to reference Galvao DA, Taaffe DR, Spry N, Newton RU: Physical activity and genitourinary cancer survivorship. Recent Results Cancer Res. 2011, 186: 217-236.CrossRefPubMed Galvao DA, Taaffe DR, Spry N, Newton RU: Physical activity and genitourinary cancer survivorship. Recent Results Cancer Res. 2011, 186: 217-236.CrossRefPubMed
20.
go back to reference Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU: Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol. 2010, 28 (2): 340-347. 10.1200/JCO.2009.23.2488.CrossRefPubMed Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU: Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol. 2010, 28 (2): 340-347. 10.1200/JCO.2009.23.2488.CrossRefPubMed
21.
go back to reference Galvao DA, Taaffe DR, Spry N, Newton RU: Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer. Prostate Cancer Prostatic Dis. 2007, 10 (4): 340-346. 10.1038/sj.pcan.4500975.CrossRefPubMed Galvao DA, Taaffe DR, Spry N, Newton RU: Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer. Prostate Cancer Prostatic Dis. 2007, 10 (4): 340-346. 10.1038/sj.pcan.4500975.CrossRefPubMed
22.
go back to reference Galvão DA, Spry N, Denham J, Taaffe DR, Cormie P, Joseph D, Lamb DS, Newton RU: A multicenter year-long randomized controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol. 2013, 3 Oct [Epub ahead of print] Galvão DA, Spry N, Denham J, Taaffe DR, Cormie P, Joseph D, Lamb DS, Newton RU: A multicenter year-long randomized controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol. 2013, 3 Oct [Epub ahead of print]
23.
go back to reference Cormie P, Newton RU, Spry N, Joseph D, Taaffe DR, Galvao DA: Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases. Prostate Cancer Prostatic Dis. 2013, Aug 6 [Epub ahead of print] Cormie P, Newton RU, Spry N, Joseph D, Taaffe DR, Galvao DA: Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases. Prostate Cancer Prostatic Dis. 2013, Aug 6 [Epub ahead of print]
24.
go back to reference Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, Venner PM, Quinney HA, Jones LW, D'Angelo ME, Wells GA: Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol. 2003, 21 (9): 1653-1659. 10.1200/JCO.2003.09.534.CrossRefPubMed Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, Venner PM, Quinney HA, Jones LW, D'Angelo ME, Wells GA: Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol. 2003, 21 (9): 1653-1659. 10.1200/JCO.2003.09.534.CrossRefPubMed
25.
go back to reference Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, Prud'Homme DG, Malone SC, Wells GA, Scott CG, Slovinec D'Angelo ME: Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol. 2009, 27 (3): 344-351.CrossRefPubMed Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, Prud'Homme DG, Malone SC, Wells GA, Scott CG, Slovinec D'Angelo ME: Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol. 2009, 27 (3): 344-351.CrossRefPubMed
26.
go back to reference Cormie P, Newton RU, Taaffe DR, Spry N, Joseph D, Akhlil Hamid M, Galvao DA: Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: a randomized controlled trial. Prostate Cancer Prostatic Dis. 2013, 16 (2): 170-175. 10.1038/pcan.2012.52.PubMed Cormie P, Newton RU, Taaffe DR, Spry N, Joseph D, Akhlil Hamid M, Galvao DA: Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: a randomized controlled trial. Prostate Cancer Prostatic Dis. 2013, 16 (2): 170-175. 10.1038/pcan.2012.52.PubMed
27.
go back to reference Cormie P, Newton RU, Taaffe DR, Spry N, Galvão DA: Exercise therapy for sexual dysfunction after prostate cancer. Nat Rev Urol. 2013, 8 October [Epub ahead of print] Cormie P, Newton RU, Taaffe DR, Spry N, Galvão DA: Exercise therapy for sexual dysfunction after prostate cancer. Nat Rev Urol. 2013, 8 October [Epub ahead of print]
28.
go back to reference Chambers SK, Pinnock C, Lepore SJ, Hughes S, O'Connell DL: A systematic review of psychosocial interventions for men with prostate cancer and their partners. Patient Educ Couns. 2011, 85 (2): e75-88. 10.1016/j.pec.2011.01.027.CrossRefPubMed Chambers SK, Pinnock C, Lepore SJ, Hughes S, O'Connell DL: A systematic review of psychosocial interventions for men with prostate cancer and their partners. Patient Educ Couns. 2011, 85 (2): e75-88. 10.1016/j.pec.2011.01.027.CrossRefPubMed
29.
go back to reference Faller H, Schuler M, Richard M, Heckl U, Weis J, Kuffner R: Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol. 2013, 31 (6): 782-793. 10.1200/JCO.2011.40.8922.CrossRefPubMed Faller H, Schuler M, Richard M, Heckl U, Weis J, Kuffner R: Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol. 2013, 31 (6): 782-793. 10.1200/JCO.2011.40.8922.CrossRefPubMed
30.
go back to reference Linden W, Girgis A: Psychological treatment outcomes for cancer patients: what do meta-analyses tell us about distress reduction?. Psychooncology. 2012, 21 (4): 343-350. 10.1002/pon.2035.CrossRefPubMed Linden W, Girgis A: Psychological treatment outcomes for cancer patients: what do meta-analyses tell us about distress reduction?. Psychooncology. 2012, 21 (4): 343-350. 10.1002/pon.2035.CrossRefPubMed
31.
go back to reference Chambers SK, Ferguson M, Gardiner RA, Aitken J, Occhipinti S: Intervening to improve psychological outcomes for men with prostate cancer. Psychooncology. 2013, 22 (5): 1025-1034. 10.1002/pon.3095.CrossRefPubMed Chambers SK, Ferguson M, Gardiner RA, Aitken J, Occhipinti S: Intervening to improve psychological outcomes for men with prostate cancer. Psychooncology. 2013, 22 (5): 1025-1034. 10.1002/pon.3095.CrossRefPubMed
32.
go back to reference Canada AL, Neese LE, Sui D, Schover LR: Pilot intervention to enhance sexual rehabilitation for couples after treatment for localized prostate carcinoma. Cancer. 2005, 104 (12): 2689-2700. 10.1002/cncr.21537.CrossRefPubMed Canada AL, Neese LE, Sui D, Schover LR: Pilot intervention to enhance sexual rehabilitation for couples after treatment for localized prostate carcinoma. Cancer. 2005, 104 (12): 2689-2700. 10.1002/cncr.21537.CrossRefPubMed
33.
go back to reference Schover LR, Canada AL, Yuan Y, Sui D, Neese L, Jenkins R, Rhodes MM: A randomized trial of internet-based versus traditional sexual counseling for couples after localized prostate cancer treatment. Cancer. 2012, 118 (2): 500-509. 10.1002/cncr.26308.CrossRefPubMed Schover LR, Canada AL, Yuan Y, Sui D, Neese L, Jenkins R, Rhodes MM: A randomized trial of internet-based versus traditional sexual counseling for couples after localized prostate cancer treatment. Cancer. 2012, 118 (2): 500-509. 10.1002/cncr.26308.CrossRefPubMed
34.
go back to reference Schover LR, Fouladi RT, Warneke CL, Neese L, Klein EA, Zippe C, Kupelian PA: The use of treatments for erectile dysfunction among survivors of prostate carcinoma. Cancer. 2002, 95 (11): 2397-2407. 10.1002/cncr.10970.CrossRefPubMed Schover LR, Fouladi RT, Warneke CL, Neese L, Klein EA, Zippe C, Kupelian PA: The use of treatments for erectile dysfunction among survivors of prostate carcinoma. Cancer. 2002, 95 (11): 2397-2407. 10.1002/cncr.10970.CrossRefPubMed
35.
go back to reference Stephenson RA, Mori M, Hsieh YC, Beer TM, Stanford JL, Gilliland FD, Hoffman RM, Potosky AL: Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study. J Urol. 2005, 174 (2): 646-650. 10.1097/01.ju.0000165342.85300.14. discussion 650CrossRefPubMed Stephenson RA, Mori M, Hsieh YC, Beer TM, Stanford JL, Gilliland FD, Hoffman RM, Potosky AL: Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study. J Urol. 2005, 174 (2): 646-650. 10.1097/01.ju.0000165342.85300.14. discussion 650CrossRefPubMed
36.
go back to reference Tal R, Jacks LM, Elkin E, Mulhall JP: Penile implant utilization following treatment for prostate cancer: analysis of the SEER-Medicare database. J Sex Med. 2011, 8 (6): 1797-1804. 10.1111/j.1743-6109.2011.02240.x.CrossRefPubMed Tal R, Jacks LM, Elkin E, Mulhall JP: Penile implant utilization following treatment for prostate cancer: analysis of the SEER-Medicare database. J Sex Med. 2011, 8 (6): 1797-1804. 10.1111/j.1743-6109.2011.02240.x.CrossRefPubMed
37.
go back to reference Addis ME, Mahalik JR: Men, masculinity, and the contexts of help seeking. Am Psychol. 2003, 58 (1): 5-14.CrossRefPubMed Addis ME, Mahalik JR: Men, masculinity, and the contexts of help seeking. Am Psychol. 2003, 58 (1): 5-14.CrossRefPubMed
38.
go back to reference Galdas PM, Cheater F, Marshall P: Men and health help-seeking behaviour: literature review. J Adv Nurs. 2005, 49 (6): 616-623. 10.1111/j.1365-2648.2004.03331.x.CrossRefPubMed Galdas PM, Cheater F, Marshall P: Men and health help-seeking behaviour: literature review. J Adv Nurs. 2005, 49 (6): 616-623. 10.1111/j.1365-2648.2004.03331.x.CrossRefPubMed
39.
go back to reference Smith JA, Braunack-Mayer A, Wittert G: What do we know about men's help-seeking and health service use?. Med J Aust. 2006, 184 (2): 81-83.PubMed Smith JA, Braunack-Mayer A, Wittert G: What do we know about men's help-seeking and health service use?. Med J Aust. 2006, 184 (2): 81-83.PubMed
40.
go back to reference Schulz KF, Altman DG, Moher D: CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010, 8: 18-10.1186/1741-7015-8-18.CrossRefPubMedPubMedCentral Schulz KF, Altman DG, Moher D: CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010, 8: 18-10.1186/1741-7015-8-18.CrossRefPubMedPubMedCentral
41.
go back to reference Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A: The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997, 49 (6): 822-830. 10.1016/S0090-4295(97)00238-0.CrossRefPubMed Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A: The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997, 49 (6): 822-830. 10.1016/S0090-4295(97)00238-0.CrossRefPubMed
42.
go back to reference Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG: Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000, 56 (6): 899-905. 10.1016/S0090-4295(00)00858-X.CrossRefPubMed Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG: Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000, 56 (6): 899-905. 10.1016/S0090-4295(00)00858-X.CrossRefPubMed
43.
go back to reference van Andel G, Bottomley A, Fossa SD, Efficace F, Coens C, Guerif S, Kynaston H, Gontero P, Thalmann G, Akdas A, D'Haese S, Aaronson NK: An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer. 2008, 44 (16): 2418-2424. 10.1016/j.ejca.2008.07.030.CrossRefPubMed van Andel G, Bottomley A, Fossa SD, Efficace F, Coens C, Guerif S, Kynaston H, Gontero P, Thalmann G, Akdas A, D'Haese S, Aaronson NK: An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer. 2008, 44 (16): 2418-2424. 10.1016/j.ejca.2008.07.030.CrossRefPubMed
44.
go back to reference Swindle R, Cameron A, Rosen R: A 15-item short form of the psychological and interpersonal relationship scales. Int J Impot Res. 2006, 18 (1): 82-88. 10.1038/sj.ijir.3901381.CrossRefPubMed Swindle R, Cameron A, Rosen R: A 15-item short form of the psychological and interpersonal relationship scales. Int J Impot Res. 2006, 18 (1): 82-88. 10.1038/sj.ijir.3901381.CrossRefPubMed
45.
go back to reference Libman E, Rothenberg I, Fichten CS, Amsel R: The SSES-E: a measure of sexual self-efficacy in erectile functioning. J Sex Marital Ther. 1985, 11 (4): 233-247. 10.1080/00926238508405450.CrossRefPubMed Libman E, Rothenberg I, Fichten CS, Amsel R: The SSES-E: a measure of sexual self-efficacy in erectile functioning. J Sex Marital Ther. 1985, 11 (4): 233-247. 10.1080/00926238508405450.CrossRefPubMed
46.
go back to reference Clark JA, Bokhour BG, Inui TS, Silliman RA, Talcott JA: Measuring patients' perceptions of the outcomes of treatment for early prostate cancer. Med Care. 2003, 41 (8): 923-936. 10.1097/00005650-200308000-00006.CrossRefPubMed Clark JA, Bokhour BG, Inui TS, Silliman RA, Talcott JA: Measuring patients' perceptions of the outcomes of treatment for early prostate cancer. Med Care. 2003, 41 (8): 923-936. 10.1097/00005650-200308000-00006.CrossRefPubMed
47.
go back to reference Spence JT, Helmreich RL: Masculinity and femininity: their psychological dimensions, correlates, and antecedents. 1978, Austin, Texas: University of Texas Press Spence JT, Helmreich RL: Masculinity and femininity: their psychological dimensions, correlates, and antecedents. 1978, Austin, Texas: University of Texas Press
48.
go back to reference Chambers SK, Schover L, Halford K, Clutton S, Ferguson M, Gordon L, Gardiner RA, Occhipinti S, Dunn J: ProsCan for couples: randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer who receive radical prostatectomy. BMC Cancer. 2008, 8 (1): 226-10.1186/1471-2407-8-226.CrossRefPubMedPubMedCentral Chambers SK, Schover L, Halford K, Clutton S, Ferguson M, Gordon L, Gardiner RA, Occhipinti S, Dunn J: ProsCan for couples: randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer who receive radical prostatectomy. BMC Cancer. 2008, 8 (1): 226-10.1186/1471-2407-8-226.CrossRefPubMedPubMedCentral
49.
go back to reference Sharpley C, Cross D: A psychometric evaluation of the Spanier Dyadic Adjustment Scale. J Marriage Fam. 1982, 44: 739-741. 10.2307/351594.CrossRef Sharpley C, Cross D: A psychometric evaluation of the Spanier Dyadic Adjustment Scale. J Marriage Fam. 1982, 44: 739-741. 10.2307/351594.CrossRef
50.
go back to reference Bonevski B, Sanson-Fisher R, Girgis A, Burton L, Cook P, Boyes A: Evaluation of an instrument to assess the needs of patients with cancer. Supportive Care Review Group. Cancer. 2000, 88 (1): 217-225. 10.1002/(SICI)1097-0142(20000101)88:1<217::AID-CNCR29>3.0.CO;2-Y.CrossRefPubMed Bonevski B, Sanson-Fisher R, Girgis A, Burton L, Cook P, Boyes A: Evaluation of an instrument to assess the needs of patients with cancer. Supportive Care Review Group. Cancer. 2000, 88 (1): 217-225. 10.1002/(SICI)1097-0142(20000101)88:1<217::AID-CNCR29>3.0.CO;2-Y.CrossRefPubMed
51.
go back to reference Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Med Care. 1992, 30 (6): 473-483. 10.1097/00005650-199206000-00002.CrossRefPubMed Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Med Care. 1992, 30 (6): 473-483. 10.1097/00005650-199206000-00002.CrossRefPubMed
52.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993, 85 (5): 365-376. 10.1093/jnci/85.5.365.CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993, 85 (5): 365-376. 10.1093/jnci/85.5.365.CrossRefPubMed
53.
go back to reference Zabora J, BrintzenhofeSzoc K, Jacobsen P, Curbow B, Piantadosi S, Hooker C, Owens A, Derogatis L: A new psychosocial screening instrument for use with cancer patients. Psychosomatics. 2001, 42 (3): 241-246. 10.1176/appi.psy.42.3.241.CrossRefPubMed Zabora J, BrintzenhofeSzoc K, Jacobsen P, Curbow B, Piantadosi S, Hooker C, Owens A, Derogatis L: A new psychosocial screening instrument for use with cancer patients. Psychosomatics. 2001, 42 (3): 241-246. 10.1176/appi.psy.42.3.241.CrossRefPubMed
54.
go back to reference Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E: Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997, 13 (2): 63-74. 10.1016/S0885-3924(96)00274-6.CrossRefPubMed Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E: Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997, 13 (2): 63-74. 10.1016/S0885-3924(96)00274-6.CrossRefPubMed
55.
go back to reference Galvao DA, Spry NA, Taaffe DR, Newton RU, Stanley J, Shannon T, Rowling C, Prince R: Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU Int. 2008, 102 (1): 44-47. 10.1111/j.1464-410X.2008.07539.x.CrossRefPubMed Galvao DA, Spry NA, Taaffe DR, Newton RU, Stanley J, Shannon T, Rowling C, Prince R: Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU Int. 2008, 102 (1): 44-47. 10.1111/j.1464-410X.2008.07539.x.CrossRefPubMed
56.
go back to reference Hopwood P, Fletcher I, Lee A, Al Ghazal S: A body image scale for use with cancer patients. Eur J Cancer. 2001, 37: 189-197.CrossRefPubMed Hopwood P, Fletcher I, Lee A, Al Ghazal S: A body image scale for use with cancer patients. Eur J Cancer. 2001, 37: 189-197.CrossRefPubMed
57.
go back to reference Newton RU, Taaffe DR, Spry N, Cormie P, Chambers SK, Gardiner RA, Shum DH, Joseph D, Galvao DA: Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation?. BMC Cancer. 2012, 12: 432-10.1186/1471-2407-12-432.CrossRefPubMedPubMedCentral Newton RU, Taaffe DR, Spry N, Cormie P, Chambers SK, Gardiner RA, Shum DH, Joseph D, Galvao DA: Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation?. BMC Cancer. 2012, 12: 432-10.1186/1471-2407-12-432.CrossRefPubMedPubMedCentral
58.
go back to reference Plasqui G, Westerterp KR: Physical activity assessment with accelerometers: an evaluation against doubly labeled water. Obesity (Silver Spring). 2007, 15 (10): 2371-2379. 10.1038/oby.2007.281.CrossRef Plasqui G, Westerterp KR: Physical activity assessment with accelerometers: an evaluation against doubly labeled water. Obesity (Silver Spring). 2007, 15 (10): 2371-2379. 10.1038/oby.2007.281.CrossRef
59.
go back to reference Jacobs DR, Ainsworth BE, Hartman TJ, Leon AS: A simultaneous evaluation of 10 commonly used physical activity questionnaires. Med Sci Sports Exerc. 1993, 25 (1): 81-91. 10.1249/00005768-199301000-00012.CrossRefPubMed Jacobs DR, Ainsworth BE, Hartman TJ, Leon AS: A simultaneous evaluation of 10 commonly used physical activity questionnaires. Med Sci Sports Exerc. 1993, 25 (1): 81-91. 10.1249/00005768-199301000-00012.CrossRefPubMed
60.
go back to reference Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen VE, Schwartz AL, American College of Sports Medicine: American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010, 42 (7): 1409-1426. 10.1249/MSS.0b013e3181e0c112.CrossRefPubMed Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen VE, Schwartz AL, American College of Sports Medicine: American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010, 42 (7): 1409-1426. 10.1249/MSS.0b013e3181e0c112.CrossRefPubMed
61.
go back to reference Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, Bandera EV, Hamilton KK, Grant B, McCullough M, Tim B, Ted G: Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012, 62 (4): 242-274. 10.3322/caac.21142.CrossRef Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, Bandera EV, Hamilton KK, Grant B, McCullough M, Tim B, Ted G: Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012, 62 (4): 242-274. 10.3322/caac.21142.CrossRef
62.
go back to reference Bennett-Levy J, Richards D, Farrand P: Low Intensity CBT Interventions: A Revolution in Mental Health Services. Oxford Guide to Low Intensity CBT Interventions. Edited by: Bennett-Levy J, Richards D, Farrand P. 2010, Oxford: Oxford University Press, 3-18.CrossRef Bennett-Levy J, Richards D, Farrand P: Low Intensity CBT Interventions: A Revolution in Mental Health Services. Oxford Guide to Low Intensity CBT Interventions. Edited by: Bennett-Levy J, Richards D, Farrand P. 2010, Oxford: Oxford University Press, 3-18.CrossRef
63.
go back to reference Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J: Self-management approaches for people with chronic conditions: a review. Patient Educ Couns. 2002, 48 (2): 177-187. 10.1016/S0738-3991(02)00032-0.CrossRefPubMed Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J: Self-management approaches for people with chronic conditions: a review. Patient Educ Couns. 2002, 48 (2): 177-187. 10.1016/S0738-3991(02)00032-0.CrossRefPubMed
64.
go back to reference Chambers SK: Facing the Tiger A Guide for Men with Prostate Cancer and the People who Love Them. 2013, Samford Valley, Australia: Australian Academic Press Chambers SK: Facing the Tiger A Guide for Men with Prostate Cancer and the People who Love Them. 2013, Samford Valley, Australia: Australian Academic Press
65.
go back to reference Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M, Ogedegbe G, Orwig D, Ernst D, Czajkowski S: Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol. 2004, 23 (5): 443-451.CrossRefPubMed Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M, Ogedegbe G, Orwig D, Ernst D, Czajkowski S: Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol. 2004, 23 (5): 443-451.CrossRefPubMed
66.
go back to reference Klaeson K, Sandell K, Bertero CM: Sexuality in the context of prostate cancer narratives. Qual Health Res. 2012, 22 (9): 1184-1194. 10.1177/1049732312449208.CrossRefPubMed Klaeson K, Sandell K, Bertero CM: Sexuality in the context of prostate cancer narratives. Qual Health Res. 2012, 22 (9): 1184-1194. 10.1177/1049732312449208.CrossRefPubMed
67.
go back to reference Zaider T, Manne S, Nelson C, Mulhall J, Kissane D: Loss of masculine identity, marital affection, and sexual bother in Men with localized prostate cancer. J Sex Med. 2012, 9 (10): 2724-2732. 10.1111/j.1743-6109.2012.02897.x.CrossRefPubMed Zaider T, Manne S, Nelson C, Mulhall J, Kissane D: Loss of masculine identity, marital affection, and sexual bother in Men with localized prostate cancer. J Sex Med. 2012, 9 (10): 2724-2732. 10.1111/j.1743-6109.2012.02897.x.CrossRefPubMed
Metadata
Title
Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies
Authors
Prue Cormie
Suzanne K Chambers
Robert U Newton
Robert A Gardiner
Nigel Spry
Dennis R Taaffe
David Joseph
M Akhlil Hamid
Peter Chong
David Hughes
Kyra Hamilton
Daniel A Galvão
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-199

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine